
The Medicine Maker: ‘The Pandemic Diaries’
In this article in The Medicine Maker, our CEO, Andy Chaloner, discusses the shift in business priorities and resulting opportunities during the COVID-19 pandemic with Stephane Argivier, CEO of MIP Diagnostics.